Results 31 to 40 of about 6,249,776 (240)

Correlation functions for $$n\,\bar{D}_{s1}(2460)$$ n D ¯ s 1 ( 2460 ) and $$n\,\bar{D}_{s1}(2536)$$ n D ¯ s 1 ( 2536 )

open access: yesEuropean Physical Journal C: Particles and Fields
We study the interaction of the $$n \bar{D}_{s1}(2460)$$ n D ¯ s 1 ( 2460 ) and $$n \bar{D}_{s1}(2536)$$ n D ¯ s 1 ( 2536 ) systems from the perspective that the $$D_{s1}(2460)$$ D s 1 ( 2460 ) and $$D_{s1}(2536)$$ D s 1 ( 2536 ) states are molecular ...
Breno Agatão   +5 more
doaj   +1 more source

Techniques and Methods for Detection and Diagnosis of Oral Premalignant and Malignant Lesions [PDF]

open access: yes, 2015
ОСÐОВÐ: Оралните премалигни и малигни лезии бележат тенденција на доцна детекција, која е на штета на пациентите поради виÑоките Ñтапки нР...
Minovska, Ana   +4 more
core   +2 more sources

Results of the Childhood Cancer and Leukaemia Group's United Kingdom Relapsed Wilms Tumour Trial

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background The United Kingdom relapsed Wilms tumour (UKW‐R) trial aimed to improve the historically low survival rates after relapse of Wilms tumour (WT) through a prospective national risk‐stratified protocol. The trial also evaluated efficacy and toxicity of high‐dose melphalan.
Sucheta J. Vaidya   +10 more
wiley   +1 more source

ДејÑтво на интерферон врз фагоцитоза на леукоцитите во in vitro уÑлови [PDF]

open access: yes, 2016
In atempt to get elementary insight of interpheron action on leukocyte fagocytable capacity, in vitro were tested fagocytes from the patients with various diseases.
УгринÑки (Ugrinski), Предраг (Predrag)   +1 more
core   +1 more source

Efficacy and Tolerability of Topotecan/Cyclophosphamide/Dinutuximab in Relapsed and Refractory High‐Risk Neuroblastoma: A Multi‐Institutional Retrospective Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Purpose Chemoimmunotherapy with irinotecan, temozolomide, and dinutuximab (I/T/DIN) has emerged as first‐line therapy for relapsed/refractory (r/r) high‐risk neuroblastoma (HRNB) in North America. Topotecan and cyclophosphamide (T/C) are often used in combination with dinutuximab in the setting of lack of response, progression, or incomplete ...
Benjamin J. Lerman   +17 more
wiley   +1 more source

restauration de l'Église Notre-Dame de la Candelaria de Quinterquén, île de Caucachué, Chiloé, Chili [PDF]

open access: yes, 2019
The following article shows the path of a work team in addressing a process of heritage restoration with a community integration approach, taking up the tradition of minga as method.
Ciudad Bazaul , Cristina   +1 more
core   +1 more source

Body Dysmorphic Disorder and Aesthetic Surgery [PDF]

open access: yes, 2015
ОСÐОВÐ: Дизморфофобија, или на англиÑки Body Dismorphic Disorder (BDD)  е релативно чеÑто и многу тешко заболовање кое многу пати поминува недијагноÑÑ‚Ð¸Ñ†Ð¸Ñ ...
Breshkovska, Hristina   +3 more
core   +2 more sources

Clinical Course and Impact of Breaks in Therapy for Children With Relapsed/Refractory Solid Tumors

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Introduction Pediatric relapsed or refractory (R/R) solid tumors carry a dismal prognosis, and postrelapse patient experiences are not well described. We present postrelapse outcomes, including number of R/R events and subsequent therapy regimens.
Matthew T. McEvoy   +5 more
wiley   +1 more source

Measurement of D0, D+, D*+ and D s + production in Pb-Pb collisions at s N N = 5.02 $$ \sqrt{{\mathrm{s}}_{\mathrm{NN}}}=5.02 $$ TeV

open access: yesJournal of High Energy Physics, 2018
We report measurements of the production of prompt D0, D+, D*+ and D s + mesons in Pb–Pb collisions at the centre-of-mass energy per nucleon-nucleon pair s N N = 5.02 $$ \sqrt{s_{\mathrm{NN}}}=5.02 $$ TeV, in the centrality classes 0–10%, 30–50% and 60 ...
The ALICE collaboration   +1003 more
doaj   +1 more source

The head of the nominal is N, not D: N-to-D Movement, Hybrid Agreement, and conventionalized expressions

open access: yesGlossa, 2020
The DP Hypothesis has recently come under intense criticism (Bruening 2009, Bruening et al. 2018). In the face of this criticism, several responses have been offered. This paper addresses three such responses and shows that they are without force. First,
Benjamin Bruening
doaj   +2 more sources

Home - About - Disclaimer - Privacy